Pharmaceuticals, Biotechnology and Life Sciences
LUXEMBOURG–(BUSINESS WIRE)–In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a…
SAN DIEGO–(BUSINESS WIRE)–AvantGen, Inc., a privately-held San Diego-based biotechnology company and contract service provider, today announced it has identified and…
Sanofi and GSK today announced teaming up to work on a vaccine for COVID-19, as Sanofi will contribute its S-protein COVID-19 antigen, and GSK contributing pandemic adjuvant technology.
BIOGGIO, Switzerland–(BUSINESS WIRE)–The KD Pharma Group (“KD Pharma”) and its partner, SLA Pharma (“SLA”), announced that its new drug candidate…
Tiziana Life Sciences said Thursday it has developed investigational new technology to treat COVID-19 infections.
GlaxoSmithKline and Vir Biotechnology have signed a binding agreement to enter into a collaboration to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19, in which GSK will make an equity investment in Vir of $250 million, to gain access to Vir’s technology.
Oxford Biomedica said Wednesday it has joined a Consortium lead by the Jenner Institute, Oxford University, to work on a potential vaccine candidate for COVID-19, called ChAdOx1 nCov-19.
Pacific Biosciences of California is working with commercial, academic and government research teams that are investigating SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
IBM Releases Novel AIBM Research has been actively developing new cloud and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery.